{
  "author": {
    "name": "Dr Polina Kogan",
    "webUrl": "/author/profile/dr-polina-kogan/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 1,
    "social": [],
    "articles": [
      {
        "uri": "/2019/10/07/evaluating-your-pbm-evaluation-process-are-you-aligned-with-client-goals/",
        "title": "Evaluating your PBM evaluation process: Are you aligned with client goals?",
        "byline": "Dr. Polina Kogan",
        "kicker": "",
        "prettyDate": "October 07, 2019",
        "timeToRead": "4 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2019/10/shutterstock_1146762413-1.jpg",
          "width": "750",
          "height": "500"
        },
        "authors": [
          {
            "webUrl": "/author/profile/dr-polina-kogan/",
            "name": "Dr. Polina Kogan"
          }
        ],
        "kickerNode": [],
        "summary": "While the medical health care industry is transitioning from the broken fee-for-service model by incorporating capitated payments and responsible risk-assumption, pharmacy pricing structures still very much value volume.",
        "body": null
      }
    ]
  }
}